Clinical Diagnostics
-
Combined Autoantibody Screening Emerges as Critical Tool for Early Detection of Latent Autoimmune Diabetes in Adults
A 2023 Lancet study reveals 15-20% of type 2 diabetes patients exhibit autoimmune markers, with new ADA guidelines advocating combined GADA/ICA/IAA testing to prevent diagnostic…